Member Info for RonnieB

Construction costs have soared over the last 2 years by 25-30% especially with structural steel and cladding. Plant development costs have probably been a factor.

The Company will further outline its commitment to execution of and progress with its strategic shift in its 2023 interim results, due for publication by the end of September 2023.mmmmmmmmmmm

UJO has had a solid income stream the last 2 years with lots of cash in reserve and no bondholders to pay. Lets wait till end of month, if the pump does the job we should bounce hard.

Claire Coutinho appointed energy secretary and voted against Labour motion to ban fracking. It was Liz Truss support for fracking last year that sent these oil shares rocketing, perhaps a change in policy in the near future?

Forget takeover the offer would be too low. Positives are Italy up and running, next Croatia and France all providing revenue streams; 25% slashed of wage bill; refinancing of Italy project. If Southport and Billingham get closure it will be the rabbits pulled out of the hat.

Cash burn significantly reduced, no imminent placing is required which is the main positive out of this. This could 4 bag on new contract.

Best we can hope for is cash balance of £4.4m which is crucial. If the cash flow is stable we should re-rate. The cash burn has been the major factor in share price decline.

Amigo loans is the subsidiary of Amigo Holdings. The £97m is ring fenced, wind down Amigo Loans. After Amigo loans is wound down create new subsidiary Amigo Loans 2 with the same platform.

Interim results due by end of next week, will be interesting to see progress if any!

Will the revenue from the Italian, French & Croatian plants once all operational be enough to get EQT cash flow positive?
EQT have been churning through approx £7m per annum and the falling share price is making further placings unsustainable. Also construction costs have increased considerably along with higher interest rates and now banking crisis.
Remember this 30 bagged from Dec 2020 to Jan 2021; Market cap went from £7m to £300m and now £17m.

I see we had twice the buys than sells today. A positive at least. I wonder if we will see an offer being made next week?

Currently engaged with the FCA; now we await their response!
If positive its game on; if not then game over.
With future of the business and jobs losses at risk will the FCA be flexible or not?

What is the situation with Italy, we are now into March and nothing, thought it was ready for commissioning back in December? Or is DP waiting to release a string of game changing RNSs?

I assume with the $1m upfront cash no placing is required? The RNS did'nt exactly clarify this. Is ECHO now cash flow positive? Any opinions?

I assume the next RNS will be FDA submission.

Can anyone confirm the true market cap of HEMO, here it is £24m but on ADVFN it is £13.

The herd now arriving, short term price target 10-20p on potential alone. Ducks lining up nicely and still so undervalued at this level.

Rumour has it health trusts are considering re-introducing LFT.

Now we are moving.

FWIW I would rather buy now at 0.4p than before today.